Antiglaucoma preparations and miotics

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: Ophthalmological surgery	77.90%
INSURED CONSUMERS
% of insured consumers	2.13%
Median age	72 years
Max/min ratio of the median age (by district)	1.04
Percentage of women	53.86%
Ratio Preferential scheme/General scheme	1.25
Coefficient of variation (2022)	20.59
Max/min ratio of % of insured consumers (by district)	2.79
CONSUMPTION
Annual consumption (DDD)	98,207,486
Consumption of DDD (per 100,000 insured persons)	856,353.89
% DDD issued outside the insurance (approximate)	6.20%
Average annual consumption per insured consumer (DDD)	402.74
% of insured consumers with > 3 times the average consumption	4.85%
Coefficient of variation (% of insured consumers) 2012-2014	16.67
Coefficient of variation (% of insured consumers) 2020-2022	16.61
Trend 2012-2022	4.50%
Trend 2012-2019	5.60%
Trend 2019-2022	1.99%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	19,606,835€
Average annual expenditure per insured person	1.71 €
Average patient share per insured consumer	22.40%
Max/min ratio of expenditure per insured person (by disctrict)	1.88
% “Low-cost” medication	81.59%
Trend 2012-2022	-3.59%
Trend 2019-2022	-0.11%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES (ATC-5)	LABELS
S01EA	SYMPATHOMIMETICS IN GLAUCOMA THERAPY
S01EB	PARASYMPATHOMIMETICS
S01EC	CARBONIC ANHYDRASE INHIBITORS
S01ED	BETA BLOCKING AGENTS
S01EE	PROSTAGLANDIN ANALOGUES